Customer Development Developer Lean SBIR 
Steve Blank
JUNE 19, 2014
Today the National Institutes of Health announced they are offering my Lean LaunchPad class ( I-Corps @ NIH ) to commercialize Life Science. 110 researchers and clinicians, and Principal Investigators got out of the lab and hospital, and talked to 2,355 customers, tested 947 hypotheses and invalidated 423 of them.
Steve Blank
AUGUST 21, 2013
We’re going to test this hypothesis by teaching a Lean LaunchPad class for Life Sciences and Health Care (therapeutics, diagnostics, devices and digital health) this October at UCSF with a team of veteran venture capitalists. The teams that took the Lean Launchpad class – get ready for this – had a 60% success rate.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Steve Blank
JUNE 8, 2021
This was followed by an 8-minute slide presentation describing their customer discovery journey over the 10 weeks. While all the teams used the Mission Model Canvas , (videos here ), Customer Development and Agile Engineering to build Minimal Viable Products, each of their journeys was unique.
Steve Blank
JUNE 12, 2020
This was followed by an 8-minute slide presentation describing their customer discovery journey over the 10-weeks. All the teams used the Mission Model Canvas , (videos here ) Customer Development and Agile Engineering to build Minimal Viable Products, but all of their journeys were unique.
Steve Blank
MAY 12, 2015
After seeing the results of 500+ teams through the I-Corps, the NSF now offers all teams who’ve received government funding to start a company an introduction to building a Lean Startup. SBIR/STTR Program and Startup Seed Funding. The SBIR/STTR program represents a critical source of seed funding for U.S. The SBIR/STTR program.
Steve Blank
JUNE 7, 2019
Followed by an 8-minute slide presentation follow their customer discovery journey over the 10-weeks. All the teams used the Mission Model Canvas , Customer Development and Agile Engineering to build Minimal Viable Products, but all of their journeys were unique. All the presentations are worth a watch. Team: Panacea.
Steve Blank
DECEMBER 17, 2014
With that SBIR-Phase 1 funding the teams were trying to establish the technical merit, feasibility, and commercial potential of their technology. BCN is developing a drug that increases anti-cancer effect of radiation in lung cancer (and/or reduces normal tissue damage by at least 40%). Like a startup it’s relentless.
Expert insights. Personalized for you.
269 
Let's personalize your content